Friday, August 14, 2026

KT’s New Era: How CEO Park Yoon-young Plans to Transform the Company into an AI-Driven AX Platform

Park Yoon-young becomes KT's CEO, aiming to transform the company into an AI-focused AX Platform with strong growth and security.

Revolutionary Low-Dose 3-Drug Combo: The Future of Hypertension Treatment in 2026

A study shows a new combination pill for hypertension is safer and more effective than traditional treatments, improving patient adherence.

Pig on a Throne: Insider Reveals How Kim Jong Un Uses Starvation Money To Buy Yachts and Nuclear Missiles

Former North Korean diplomat Ryu Hyun-woo reveals Kim Jong-un's secret slush fund in a new book, exposing the regime's financial realities.

Tag: cholangiocarcinoma

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

How to Detect Bile Duct Cancer: Jaundice, Itching, Abdominal Pain, and Weight Loss

Cholangiocarcinoma, or bile duct cancer, has a poor prognosis due to late detection; early diagnosis is crucial for better outcomes.

FDA Grants Orphan Drug Status to Tovecimig: What This Means for Cholangiocarcinoma Treatment

ABL Bio's Tovecimig receives Orphan Drug Designation from the FDA, enhancing its approval prospects for cholangiocarcinoma treatment.

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.